Initiator Pharma A/S

Research Initiator Pharma A/S (INIT) on Bullrun: market cap SEK 195.09M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerINIT
• ExchangeST
• CountryDenmark
• SectorHealthcare
• IndustryBiotechnology
• CurrencySEK
• Market capSEK 195.09M
• Financial periodQ4 2025
• Net income-SEK 2.92M
• Free cash flow-SEK 2.43M

Valuation Snapshot

latest market cap is SEK 195.09M.

About Initiator Pharma A/S

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system. Its product pipeline includes Pudafensine, a monoamine reuptake inhibitor, which completed phase IIb clinical trial primarily targeting the dopamine system for treatment resistant organic erectile dysfunction, as well as completed phase I to treat neuropathic pain;

Frequently asked questions

What is Initiator Pharma A/S's market cap?

Initiator Pharma A/S's market capitalization is SEK 195.09M.

What does Initiator Pharma A/S do?

Initiator Pharma A/S, a clinical stage life science company, develops drugs targeting unmet medical needs within the central and peripheral nervous system.